Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini oral session: Supportive and palliative care

430MO - Impact of Nada yoga music therapy on anxiety and quality of life in ovarian cancer patients: A randomized controlled trial

Date

02 Dec 2023

Session

Mini oral session: Supportive and palliative care

Topics

Supportive Care and Symptom Management;  Clinical Research

Tumour Site

Ovarian Cancer

Presenters

Sweta Malik

Citation

Annals of Oncology (2023) 34 (suppl_4): S1632-S1645. 10.1016/annonc/annonc1388

Authors

S. Malik1, A. Sehrawat2, R. Kumari3, S.L. Barnwal4, S. Kalra5, R. Singh6, P. Bhardwaj7, T. Dogra1, S. Gupta8, S. Saini9, N. Sinha2, J. Chaturvedi1

Author affiliations

  • 1 Department Of Obstetrics And Gynaecology, All India Institute of Medical Sciences Rishikesh, 249203 - Rishikesh/IN
  • 2 Medical Oncology Department, All India Institute of Medical Sciences Rishikesh, 249203 - Rishikesh/IN
  • 3 Department Of Community And Family Medicine, All India Institute of Medical Sciences Rishikesh, 249203 - Rishikesh/IN
  • 4 Department Of Yoga And Health, Dev Sanskriti Vishwavidyalaya, 249411 - Haridwar/IN
  • 5 Department Of Computer Science And Engineering, Department Of Smart Healthcare Interdisciplinary Research Program, IITJ - Indian Institute of Technology Jodhpur, 342037 - Jodhpur/IN
  • 6 Department Of Yoga, Mohan Lal Sukhadia University, 313001 - Udaipur/IN
  • 7 Department Of Medicine, All India Institute of Medical Sciences Rishikesh, 249203 - Rishikesh/IN
  • 8 Radiation Oncology Department, All India Institute of Medical Sciences Rishikesh, 249203 - Rishikesh/IN
  • 9 Medical Oncology Department, Cancer Research Institute, Swami Rama Himalayan University, 248016 - Dehradun/IN

Resources

This content is available to ESMO members and event participants.

Abstract 430MO

Background

Nadayoga is a complementary therapy known for its potential to reduce anxiety. This study aimed to assess the effects of Nadayoga music on anxiety management and Quality of Life (QoL) in ovarian cancer patients undergoing chemotherapy.

Methods

In this randomized controlled trial, 58 ovarian cancer patients undergoing chemotherapy were recruited. Participants were randomly assigned to either the Nada yoga music group (Group A) or the Nada yoga music with Instruction group (Group B) using a simple randomization procedure. Instructions for Nada yoga music were recorded by the researcher and delivered to both groups through a custom Android application developed for this study. Follow-up assessments were conducted every three weeks, and anxiety levels were measured using the Hamilton Anxiety Rating Scale, while QoL was assessed using the EORTC QLQ-C30 Quality of Life Questionnaire. Baseline data was collected just before the first chemotherapy session, and post-data was collected after 12 weeks.

Results

Data from 49 participants were included in the analysis according to the protocol. Both groups were found to be homogenous with respect to age, weight, and clinical parameters. Significant differences were observed in anxiety scores between the two groups (p = 0.026). Furthermore, a notable improvement in global health status was noted in both groups (p = 0.039). However, no significant changes were observed in physical functioning (p = 0.390), role functioning (p = 0.453), emotional functioning (p = 0.192), cognitive functioning (p = 0.190), or social functioning (p = 0.282). Significant differences were observed in fatigue (p = 0.039), nausea/vomiting (p = 0.009), dyspnoea (p = 0.011), and financial difficulties (p = 0.006) between the two groups, favouring intervention arm.

Conclusions

In conclusion, the twelve-week Nadayoga music therapy intervention offers a cost-effective approach to reducing anxiety and improving the quality of life for ovarian cancer patients. This study highlights the potential of Nadayoga music therapy as a valuable addition to comprehensive cancer care, emphasizing its positive impact on emotional well-being and symptom management.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.